Form 4: Moderna Director Elizabeth Tallett Reports Stock Transactions

Moderna, Inc. Director Elizabeth E. Tallett reported transactions involving restricted stock units and common stock on April 30, 2026.

Summary

• Elizabeth E. Tallett, a Director at Moderna, Inc., reported the conversion of restricted stock units (RSUs) into common stock on April 30, 2026.
• A total of 4,058 restricted stock units vested and converted into 4,058 shares of common stock.
• Following these transactions, Ms. Tallett beneficially owns 4,761 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of insider stock transactions (vesting of RSUs) rather than a significant strategic announcement or financial performance update.

Positives

• Director Elizabeth E. Tallett's restricted stock units vested, converting into common stock, indicating the fulfillment of equity awards.
• The vesting of 4,058 restricted stock units on April 30, 2026, demonstrates the company's commitment to its compensation plans for key personnel.

Future Outlook

This filing is a routine disclosure of stock transactions by a director and does not contain forward-looking statements or guidance regarding the company's financial performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider stock transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors monitoring insider sentiment and potential shifts in beneficial ownership.

Stakeholder Impact

• Shareholders: Provides transparency into insider holdings and potential alignment of interests through equity awards.

Key Dates

Keywords

Moderna, MRNA, Form 4, SEC Filing, Stock Transaction, Restricted Stock Units, Common Stock, Beneficial Ownership, Director